US : NGM Biopharmaceuticals, Inc. - NGM | 1Q21 Update: 2Q Brings ALPINE 2/3 Data and Merck Collaboration Decision

Most Viewed See latest

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers